Remove Blog Remove Finance Remove Individual Remove Provider
article thumbnail

How Doctors Should Address Lifestyle Creep

The Motivated MD

Though I adhere to commonly agreed upon personal finance advice such as living ‘like a resident’ and well below your means, if you are overly frugal, you will deprive yourself of the enjoyment that is deserved when your income grows. Allowing ourselves to spend our hard-earned money is critical to finding happiness in our careers.

Finance 52
article thumbnail

Lessons Learned From My Hiatus

The Motivated MD

For many who follow the blog regularly, you likely have noticed that I haven’t published a blog post in quite some time (a month or two). Last, but not least, I genuinely felt as if I was running out of ways to provide useful and entertaining financial content. Keeping a personal finance blog is a tricky thing.

Finance 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Be The Market: How Doctors Should Invest Their Money

The Motivated MD

As I continue onward in my journey writing a physician finance guide one chapter at a time, I wanted to tackle investing. How, then, can any physician find the time to research individual companies and make educated decisions on which publicly traded businesses are undervalued? Don’t try to beat the market; be the market. Do not worry.

Finance 52
article thumbnail

Should Recent Weather Events Impact Your Emergency Fund?

The Motivated MD

Many who follow this blog know that I reside in South Carolina. However, this is a personal finance blog, and for me, it goes beyond that. Helene highlighted that even wealthy communities and well-financed and well-educated populations can be caught off guard and devastated. It has aged well I believe. expense).

article thumbnail

Drug Pricing Reform Gathers Steam (Part 1): White House Drug Pricing Plan Offers Laundry List of Existing Democrat Priorities

FDA Law Blog

Currently, individual Medicare Part D plan sponsors negotiate rebates but the government is explicitly prohibited from interfering in those negotiations. The Plan supports legislation to expedite market entry of biosimilars and generics by providing federal support to develop nonprofit generic drug manufacturers.